Literature DB >> 19827132

Upregulation of oxidative stress markers in human microvascular endothelial cells by complexes of serum albumin and digestion products of glycated casein.

Permal Deo1, Josephine V Glenn, Lesley A Powell, Alan W Stitt, Jennifer M Ames.   

Abstract

The extent of absorption of dietary advanced glycation end products (AGEs) is not fully known. The possible physiological impact of these absorbed components on inflammatory processes has been studied little and was the aim of this investigation. Aqueous solutions of bovine casein and glucose were heated at 95 degrees C for 5 h to give AGE-casein (AGE-Cas). Simulated stomach and small intestine digestion of AGE-Cas and dialysis (molecular mass cutoff of membrane = 1 kDa) resulted in a low molecular mass (LMM) fraction of digestion products, which was used to prepare bovine serum albumin (BSA)-LMM-AGE-Cas complexes. Stimulation of human microvascular endothelial cells with BSA-LMM-AGE-Cas complexes significantly increased mRNA expression of the receptor of AGE (RAGE), galectin-3 (AGE-R3), tumor necrosis factor alpha, and a marker of the mitogen-activated protein kinase pathway (MAPK-1), as well as p65NF-kappaB activation. Cells treated with LMM digestion products of AGE-Cas significantly increased AGE-R3 mRNA expression. Intracellular reactive oxygen species production increased significantly in cells challenged with BSA-LMM-AGE-Cas and LMM-AGE-Cas. In conclusion, in an in vitro cell system, digested dietary AGEs complexed with serum albumin play a role in the regulation of RAGE and downstream inflammatory pathways. AGE-R3 may protect against these effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19827132     DOI: 10.1002/jbt.20301

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  8 in total

1.  Characterization of antioxidant and anti-inflammatory activities of bioactive fractions recovered from a glucose-lysine Maillard reaction model system.

Authors:  Xiu-Min Chen; David D Kitts
Journal:  Mol Cell Biochem       Date:  2012-01-11       Impact factor: 3.396

Review 2.  Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine.

Authors:  Jean Robert Rapin; Nicolas Wiernsperger
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

3.  Selective Inhibition on RAGE-binding AGEs Required by Bioactive Peptide Alpha-S2 Case in Protein from Goat Ethawah Breed Milk: Study of Biological Modeling.

Authors:  Fatchiyah Fatchiyah; Ferlany Hardiyanti; Nashi Widodo
Journal:  Acta Inform Med       Date:  2015-04-14

Review 4.  Galectin-3: its role in asthma and potential as an anti-inflammatory target.

Authors:  Peng Gao; Jodie L Simpson; Jie Zhang; Peter G Gibson
Journal:  Respir Res       Date:  2013-12-09

5.  Effects of Weight Loss on Advanced Glycation End Products in Subjects with and without Diabetes: A Preliminary Report.

Authors:  Permal Deo; Jennifer B Keogh; Naomi J Price; Peter M Clifton
Journal:  Int J Environ Res Public Health       Date:  2017-12-11       Impact factor: 3.390

6.  In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.

Authors:  Permal Deo; Erandi Hewawasam; Aris Karakoulakis; David J Claudie; Robert Nelson; Bradley S Simpson; Nicholas M Smith; Susan J Semple
Journal:  BMC Complement Altern Med       Date:  2016-11-04       Impact factor: 3.659

7.  Differential Effects of Dietary Patterns on Advanced Glycation end Products: A Randomized Crossover Study.

Authors:  Yoona Kim; Jennifer B Keogh; Permal Deo; Peter M Clifton
Journal:  Nutrients       Date:  2020-06-12       Impact factor: 5.717

Review 8.  Galectins in Endothelial Cell Biology and Angiogenesis: The Basics.

Authors:  Victor L Thijssen
Journal:  Biomolecules       Date:  2021-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.